Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?

Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population. We are experiencing a paradigm shift in the treatment of pancreatic cancer in the era of coronavirus disease 2019 (COVID-19) pandemic. Utilizing neoadjuvant treatment and further conducting a safe sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Moslim, Maitham A, Hall, Michael J, Meyer, Joshua E, Reddy, Sanjay S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918523/
https://www.ncbi.nlm.nih.gov/pubmed/33680873
http://dx.doi.org/10.5306/wjco.v12.i2.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918523/
https://www.ncbi.nlm.nih.gov/pubmed/33680873
http://dx.doi.org/10.5306/wjco.v12.i2.54

Ejemplares similares